Friday, 18 April 2014

Reckitt Benckiser 1st quarter IMS



Reckitt Benckiser Group is a manufacturer and marketer of branded products in household, health and personal care products, sold into nearly 200 countries from operations in over 60 countries.  I have a holding in my income portfolio (epic code: RB.) 


Reckitt Benckiser announced their first quarter IMS on 16 April.  They stated that revenue growth (ex RBP) was +5% at constant currencies and a like-for-like revenue growth (ex RBP) was +4%.
 
Total revenue was £2,368m down -6% on last year, due to a -9% negative effect from foreign exchange translations.
 
By territories like-for-like growth was:
 
ENA (Europe/North America) +2%;
 
LAPAC (Latin America/Asia/Australia & New Zealand)  +8%;
 
RUMEA (Russia/Middle East/Africa/Turkey)  +4%;
 
Food +3%
 
Pharma -11%
 
By product groupings like-for-like sales growth (excluding Food and Pharma detailed above) was:
 
Health +11%

Hygiene +2%

Home +1%

Portfolio -3%

 
Management stated that the Group is on track to achieve its FY 2014 financial targets of net revenue growth of +4-5% and flat to moderate operating margin expansion.
 
No reason to change my view on RB. and they remain a core income portfolio holding.  Management state that they expect to provide more detail on the likely disposal of the Pharmaceutical business at the time of the interim announcements. 


 


No comments:

Post a Comment